5-(N,N-dimethylsulfamoyl)-N-(5-methylthiazol-2-yl)-2-(pyrrolidin-1-yl)benzamide,
CID2519269,
ML414 compound,
NGI-1 compound,
NGI-1,
790702-57-7,
ML414,
MLS002248299,
SMR001315774,
5-(dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-(pyrrolidin-1-yl)benzamide,
5-(dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-pyrrolidin-1-ylbenzamide,
5-(N,N-Dimethylsulfamoyl)-N-(5-methylthiazol-2-yl)-2-(pyrrolidin-1-yl)benzamide,
KSC-367-096-1,
AC1M8RVC,
KUC113535N-NLG,
CHEMBL1720448,
SCHEMBL20598184,
cid_2519269,
ML414; NGI-1,
BDBM114446,
HMS3081P23,
KUC113535N,
EX-A2753,
ZINC3400706,
AKOS017066633,
KUC113535N-02,
MCULE-5903189375,
KSC-432-019-1,
HY-117383,
AK00792303,
CS-0065599,
J3.628.467F,
BRD-K40795977-001-04-3,
BRD-K40795977-001-07-6,
Z29324102,
5-(dimethylsulfamoyl)-N-(5-methyl-2-thiazolyl)-2-(1-pyrrolidinyl)benzamide,
5-(dimethylsulfamoyl)-N-(5-methylthiazol-2-yl)-2-pyrrolidino-benzamide,
5-(dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-pyrrolidin-1-yl-benzamide,
NGI-1; NGI1; NGI 1; ML414; ML 414; ML-414 inverted exclamation mark cent,
QPKGRLIYJGBKJL-UHFFFAOYSA-N,
ZINC03400706,
CID2519269,